Choose Site

In the News

Coronavirus Muddies FDA's Trajectory on Device Warning Letters, MedTech Dive

August 12, 2020

Morgan Lewis partner Dennis Gucciardo spoke with MedTech Dive for an article about the COVID-19 pandemic’s impact on the US Food and Drug Administration’s enforcement efforts. In the piece, he discussed the potential for virtual inspections. “I just don't see the time or place where a manufacturing representative is going to put on a Zoom call and go walk around the manufacturing space, said Dennis. “I just don't see that as a realistic possibility."

Read the full MedTech Dive article >>